What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in DNA methylation, Genetics, CpG site, Methylation and Molecular biology.
His DNA methylation study combines topics in areas such as Cancer research and Transcription factor.
His Genetics study frequently draws connections between related disciplines such as Computational biology.
His CpG site research incorporates themes from Bisulfite sequencing and Epigenetics.
His Methylation research is multidisciplinary, incorporating elements of Tumor suppressor gene and Epigenetics of physical exercise.
His biological study spans a wide range of topics, including DNA methyltransferase, GA-Binding Protein Transcription Factor, Regulation of gene expression, Gene and O-6-methylguanine-DNA methyltransferase.
His most cited work include:
- Integrative analysis of 111 reference human epigenomes (3776 citations)
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers (1368 citations)
- The NIH Roadmap Epigenomics Mapping Consortium (1307 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cancer research, DNA methylation, Genetics, Epigenetics and Glioma.
His research in Cancer research intersects with topics in Immunology, Cancer and Gene, Mutant.
The various areas that Joseph F. Costello examines in his DNA methylation study include Carcinogenesis, Molecular biology and Methylation.
The Methylation study combines topics in areas such as Gene expression and Epigenetics of physical exercise.
His work on Genetics deals in particular with Illumina Methylation Assay, Human genome, Differentially methylated regions, Restriction landmark genomic scanning and RNA-Directed DNA Methylation.
His work in Epigenomics tackles topics such as Computational biology which are related to areas like Genome.
He most often published in these fields:
- Cancer research (33.74%)
- DNA methylation (33.33%)
- Genetics (24.80%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (33.74%)
- Glioma (18.70%)
- Mutant (8.54%)
In recent papers he was focusing on the following fields of study:
Joseph F. Costello mainly focuses on Cancer research, Glioma, Mutant, DNA methylation and Somatic hypermutation.
The study incorporates disciplines such as Telomere, Methylation and Telomerase reverse transcriptase in addition to Cancer research.
His Glioma research is multidisciplinary, relying on both Gene, IDH1 and T-cell receptor.
Joseph F. Costello is interested in Epigenomics, which is a field of DNA methylation.
He combines subjects such as Genome-wide association study, Computational biology and Neuroscience with his study of Epigenomics.
His Carcinogenesis study integrates concerns from other disciplines, such as Bisulfite sequencing, Regulation of gene expression and Meningioma.
Between 2018 and 2021, his most popular works were:
- Longitudinal molecular trajectories of diffuse glioma in adults (92 citations)
- Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution. (50 citations)
- The DNA methylation landscape of advanced prostate cancer (26 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cancer research, Temozolomide, Somatic hypermutation, DNA methylation and Carcinogenesis.
His research on Cancer research frequently connects to adjacent areas such as Methylation.
His Methylation research integrates issues from Bisulfite sequencing, Regulation of gene expression, Deep sequencing and Somatic evolution in cancer.
His study in DNA methylation is interdisciplinary in nature, drawing from both Andrology and Transcriptome.
His study in Epigenomics extends to Carcinogenesis with its themes.
His study looks at the relationship between Epigenomics and fields such as Exome sequencing, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
